Asprant

Pharmaceutical medicines and services in India.

About Asprant

Asprant is a Healthcare company. Pharmaceutical medicines and services in India. The company has 10 employees. Its Indian entity Asprant Life Science Private Limited reported revenue of β‚Ή1.16 Cr. Asprant offers products and services including Afelon Medicine and Asphen-650 Medicine. Its focus areas include Life Sciences, Biotech Products, Syrups and Tablets and Pharmaceuticals.

Company details

Asprant Life Science Private Limited is recognized as a private company that was incorporated on 24 May 2018 in Kolkata, West Bengal. It is classified as a key entity in the pharmaceutical sector, where various medicines such as Afelon and Asphen-650 are offered. The company is managed by directors including Sutapa Chakraborty and is governed by principles of innovation and integrity. Its mission emphasizes the provision of high-quality products that contribute positively to communities and stakeholders, with a commitment to sustainability and ethical practices. Operations are supported by regional offices in Guwahati and Cuttack, ensuring wider reach.

  • Employees 10
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website asprant.com
  • Legal Name Asprant Life Science Private Limited
  • Date of Incorporation 24 May, 2018
  • Jurisdiction Kolkata, West Bengal, India
Key Metrics
  • Indian entity revenue
    ₹1.16 Cr

    FY 2025 · -10% YoY

  • Indian entity net loss
    -₹3,840

    FY 2025 · 0% margin

  • Indian entity EBITDA
    ₹3.1 Lakh

    FY 2025 · 3% margin

  • Employee Count
    10

Products & Services of Asprant

Asprant offers a comprehensive portfolio of products and services, including Afelon Medicine and Asphen-650 Medicine.

Afelon Medicine
Pharmaceutical Products

Afelon Medicine is offered as a pharmaceutical product for health applications.

Asphen-650 Medicine
Pharmaceutical Products

Asphen-650 Medicine is provided as a medicinal solution for specific health needs.

Board of directors of Asprant Life Science Private Limited (Asprant)

Asprant Life Science Private Limited is the primary company behind Asprant. The board of Asprant Life Science Private Limited currently have 4 directors; the longest-serving is Sutapa Chakraborty, appointed in 2018. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sutapa Chakraborty
DIN 08292937
Director01 Dec 20187 yrs 11 moAsprant Life Science Private Limited
Santanu Chakraborty
DIN 09488796
Director01 Feb 20224 yrs 9 moAsprant Life Science Private Limited
Raju Talukdar
DIN 09826681
Director15 Dec 20223 yrs 11 moAsprant Life Science Private Limited
Suvam Chakraborty
DIN 09826612
Additional Director29 Nov 20241 yr 11 moAsprant Life Science Private Limited

Financials of Asprant

Figures of Asprant Life Science Private Limited, the primary company behind Asprant, for FY 2025. Revenue was ₹1.16 Cr (-10% year on year). Net loss was -₹3,840 (0% margin). EBITDA was ₹3.1 Lakh (3% margin). Revenue has grown at a compounded annual rate of -7% over three years and -11% over five years.

  • ₹1.16 CrRevenue · FY 2025 · -10% YoY
  • -₹3,840Net loss · 0% margin
  • ₹3.1 LakhEBITDA · 3% margin
  • ₹1.6 LakhPaid-up capital
  • 10Employees (provident fund records)
  • -7%Revenue CAGR, 3 years
  • -11%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Asprant Life Science Private Limited are on its company page.

Premium access

Detailed financial statements for Asprant

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Asprant

Asprant has 10 employees.

The primary company behind Asprant, Asprant Life Science Private Limited, reported revenue of β‚Ή1.16 Cr for FY 2025, down 10% year on year.

Asprant Life Science Private Limited is recognized as a private company that was incorporated on 24 May 2018 in Kolkata, West Bengal. It is classified as a key entity in the pharmaceutical sector, where various medicines such as Afelon and Asphen-650 are offered. The company is managed by directors including Sutapa Chakraborty and is governed by principles of innovation and integrity. Its mission emphasizes the provision of high-quality products that contribute positively to communities and stakeholders, with a commitment to sustainability and ethical practices. Operations are supported by regional offices in Guwahati and Cuttack, ensuring wider reach.

Asprant offers Afelon Medicine and Asphen-650 Medicine.

Asprant operates through Asprant Life Science Private Limited.

The legal entities of Asprant currently have 4 directors, including Sutapa Chakraborty, Raju Talukdar, Suvam Chakraborty and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available